0001962738-26-000001.txt : 20260128 0001962738-26-000001.hdr.sgml : 20260128 20260128071308 ACCESSION NUMBER: 0001962738-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260128 DATE AS OF CHANGE: 20260128 EFFECTIVENESS DATE: 20260128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CASI Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001962738 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-571394 FILM NUMBER: 26568201 BUSINESS ADDRESS: STREET 1: 1701-1702, CHINA CENTRAL OFFICE TOWER 1 STREET 2: NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100025 BUSINESS PHONE: 86 10 6561 8789 MAIL ADDRESS: STREET 1: 1701-1702, CHINA CENTRAL OFFICE TOWER 1 STREET 2: NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100025 FORMER COMPANY: FORMER CONFORMED NAME: CASI Pharmaceuticals Holdings, Inc. DATE OF NAME CHANGE: 20230118 D 1 primary_doc.xml X0708 D LIVE 0001962738 CASI Pharmaceuticals, Inc. 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 CHINA 100025 86 10 6561 8789 CAYMAN ISLANDS CASI Pharmaceuticals Holdings, Inc. Other exempted company incorporated under the laws of the Cayman Islands true 2023 Wei-Wu He 1701-1702, China Central Office Tower 1 No. 81 Jianguo Road Chaoyang District Beijing F4 CHINA 100025 Director Zhenbo Su 1701-1702, China Central Office Tower 1 No. 81 Jianguo Road, Chaoyang District Beijing F4 CHINA 100025 Director Thomas Folinsbee 1701-1702, China Central Office Tower 1 No. 81 Jianguo Road, Chaoyang District Beijing F4 CHINA 100025 Director Alexander Y. Wu 9620 Medical Center Drive Suite 300 Rockville MD MARYLAND 20850 Director Xuebo Zeng 1701-1702, China Central Office Tower 1 No. 81 Jianguo Road, Chaoyang District Beijing F4 CHINA 100025 Director Wei Gao 1701-1702, China Central Office Tower 1 No. 81 Jianguo Road, Chaoyang District Beijing F4 CHINA 100025 Executive Officer General Counsel Kun Qian 1701-1702, China Central Office Tower 1 No. 81 Jianguo Road, Chaoyang District Beijing F4 CHINA 100025 Executive Officer Global Controller Chunhua Wang 1701-1702, China Central Office Tower 1 No. 81 Jianguo Road, Chaoyang District Beijing F4 CHINA 100025 Executive Officer Chief Operating Officer Hai Huang 1701-1702, China Central Office Tower 1 No. 81 Jianguo Road, Chaoyang District Beijing F4 CHINA 100025 Executive Officer Global Chief Commercial Officer Wei (Larry) Zhang 601 Gateway Blvd, Suite 1250 South San Francisco CA CALIFORNIA 94080 Executive Officer Vice President Alexander A. Zukiwski 601 Gateway Blvd, Suite 1250 South San Francisco CA CALIFORNIA 94080 Executive Officer Chief Medical Officer David Cory 601 Gateway Blvd, Suite 1250 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Chief Executive Officer and a member of the Board of Directors James Huang 601 Gateway Blvd, Suite 1250 South San Francisco CA CALIFORNIA 94080 Director Non-Executive Chairman of the Board Barbara Krebs-Pohl 601 Gateway Blvd, Suite 1250 South San Francisco CA CALIFORNIA 94080 Director Pharmaceuticals $5,000,001 - $25,000,000 06b false 2025-12-27 false true true true false 0 5000000 5000000 0 false 1 0 0 0 false CASI Pharmaceuticals, Inc. /s/ David Cory David Cory CEO 2026-01-27